Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 38, Issue 2, Pages 741-767
Publisher
Wiley
Online
2017-06-16
DOI
10.1002/med.21455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- α3 Chains of type V collagen regulate breast tumour growth via glypican-1
- (2017) Guorui Huang et al. Nature Communications
- Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC
- (2017) Wen Wang et al. Cancer Biomarkers
- Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients
- (2016) Yejoo Jeon et al. APMIS
- Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice
- (2016) Tatsuaki Iwama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging
- (2016) Dongling Zhu et al. BIOCONJUGATE CHEMISTRY
- Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
- (2016) Hisashi Hara et al. BRITISH JOURNAL OF CANCER
- Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker
- (2016) Eleftherios P. Diamandis et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection
- (2016) Zainen Qin et al. MACROMOLECULAR BIOSCIENCE
- Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
- (2016) Xue Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma
- (2016) Xiaobo Jia et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
- (2016) Chunguang Wang et al. Oncotarget
- Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a
- (2016) Siwei Wang et al. Oncotarget
- Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma
- (2016) Kwong-Fai Wong et al. Oncotarget
- Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
- (2016) Li Wang et al. Oncotarget
- Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
- (2016) Quach Truong et al. Journal of Cancer
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection
- (2016) Jiliang Feng et al. PLoS One
- T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
- (2015) Christina Dargel et al. GASTROENTEROLOGY
- Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation
- (2015) Xiao Cui et al. Hepatobiliary & Pancreatic Diseases International
- High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy
- (2015) Yukihiro Haruyama et al. INTERNATIONAL JOURNAL OF CANCER
- Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
- (2015) YONGLE WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
- (2015) YULIANG WANG et al. Molecular Medicine Reports
- Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
- (2015) Hirofumi Hanaoka et al. MOLECULAR PHARMACEUTICS
- Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
- (2015) Hirofumi Hanaoka et al. Nanomedicine
- Notum deacylates Wnt proteins to suppress signalling activity
- (2015) Satoshi Kakugawa et al. NATURE
- Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model
- (2015) Kui Wang et al. Small
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
- (2015) Wei Gao et al. Nature Communications
- Differential Expression of Glypican-1 in Ameloblastoma Variants
- (2015) Ronell Bologna-Molina et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Identification of glypican-3-derived long peptides activating both CD8+and CD4+T cells; prolonged overall survival in cancer patients with Th cell response
- (2015) Mohammad A. Sayem et al. OncoImmunology
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
- (2015) Wei Gao et al. PLoS One
- Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
- (2015) Chris K. Sun et al. NEOPLASIA
- Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
- (2014) Xiaobo Jia et al. ARCHIVES OF MEDICAL RESEARCH
- Can Glypican3 be Diagnostic for Early Hepatocellular Carcinoma among Egyptian Patients?
- (2014) Iman Attia Abdelgawad et al. Asian Pacific Journal of Cancer Prevention
- Imaging of hepatocellular carcinoma patient-derived xenografts using 89Zr-labeled anti-glypican-3 monoclonal antibody
- (2014) Xiaoyang Yang et al. BIOMATERIALS
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
- (2014) Hyun Jung Lee et al. Gut and Liver
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma
- (2014) Fang Luan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
- (2014) YU SAWADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
- (2014) M. Capurro et al. JOURNAL OF CELL SCIENCE
- Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular Carcinoma
- (2014) Juan-Ping Yu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software
- (2014) Chenwei Pan et al. MEDICAL ONCOLOGY
- Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells
- (2014) XIN-HUI QI et al. Molecular Medicine Reports
- Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma
- (2014) Li Gong et al. PLoS One
- Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy
- (2014) Min Yao et al. TUMOR BIOLOGY
- Neuroendocrine Tumors Show Altered Expression of Chondroitin Sulfate, Glypican 1, Glypican 5, and Syndecan 2 Depending on Their Differentiation Grade
- (2014) Olivia García-Suárez et al. Frontiers in Oncology
- Phenotypic Spectrum of Simpson-Golabi-Behmel Syndrome in a Series of 42 Cases With a Mutation in GPC 3 and Review of the Literature
- (2013) EDOUARD COTTEREAU et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions
- (2013) Eman Tawfik Enan et al. Annals of Diagnostic Pathology
- Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
- (2013) J Liang et al. BRITISH JOURNAL OF CANCER
- Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
- (2013) J.-C. Nault et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
- (2013) Min Chen et al. CLINICA CHIMICA ACTA
- Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysis
- (2013) Xiao-Fei Liu et al. CLINICAL BIOCHEMISTRY
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma
- (2013) Min Yao et al. Hepatobiliary & Pancreatic Diseases International
- MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3
- (2013) Hui-Lai Miao et al. HEPATOLOGY RESEARCH
- Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
- (2013) TATSUAKI IWAMA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Association of Glypican-4 With Body Fat Distribution, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2013) H. J. Yoo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
- (2013) I-Pei Chen et al. JOURNAL OF GASTROENTEROLOGY
- Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
- (2013) Floriane Pez et al. JOURNAL OF HEPATOLOGY
- Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients
- (2013) Gehan H. Ibrahim et al. MOLECULAR BIOLOGY REPORTS
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-1291-mediated silencing of IRE1 enhances Glypican-3 expression
- (2013) M. Maurel et al. RNA
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
- (2013) Shun-Jun Fu et al. SURGERY
- Glypican-4 is a new comer of adipokines working as insulin sensitizer
- (2013) Yoshikazu Tamori et al. Journal of Diabetes Investigation
- Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination
- (2013) Yu Sawada et al. Human Vaccines & Immunotherapeutics
- Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration Specimens
- (2012) Dana T. Timek et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Silencing glypican-3 expression induces apoptosis in human hepatocellular carcinoma cells
- (2012) Shiyuan Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
- (2012) Daisuke Nobuoka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
- (2012) Na Huang et al. FEBS LETTERS
- Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
- (2012) Silvia Tremosini et al. GUT
- Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma
- (2012) Min Yao et al. Hepatobiliary & Pancreatic Diseases International
- Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma
- (2012) Li Li et al. HEPATOLOGY
- A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma
- (2012) Marion Maurel et al. HEPATOLOGY
- Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP
- (2012) Hui-Lai Miao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
- (2012) Yen Phung et al. mAbs
- Glypican-4: role in insulin signalling
- (2012) Fiona Mitchell Nature Reviews Endocrinology
- Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA
- (2012) Dandan Yu et al. TUMOR BIOLOGY
- Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation
- (2012) Yu-Liang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study
- (2011) Lijie Zhang et al. ACTA HISTOCHEMICA
- Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma
- (2011) Bin Yan et al. Annals of Diagnostic Pathology
- Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin
- (2011) Ming-Chin Yu et al. ANNALS OF SURGICAL ONCOLOGY
- Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice
- (2011) Marta A. Kowalik et al. HEPATOLOGY
- Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
- (2011) Fuchuan Li et al. JOURNAL OF CELL BIOLOGY
- Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR
- (2011) Dong Yan et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Deregulation of Hippo kinase signalling in Human hepatic malignancies
- (2011) Hua Li et al. LIVER INTERNATIONAL
- Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients
- (2011) Su Ning et al. MOLECULAR BIOLOGY REPORTS
- Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model
- (2011) Sandra Jalvy-Delvaille et al. NUCLEIC ACIDS RESEARCH
- Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The essential role of macrophages
- (2010) Hirotake Takai et al. CANCER BIOLOGY & THERAPY
- Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma
- (2010) Hirotake Takai et al. CANCER BIOLOGY & THERAPY
- Paths of FGFR-driven tumorigenesis
- (2010) Victor D. Acevedo et al. CELL CYCLE
- Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: Associated signaling pathways, tumor phenotypes, and survival
- (2010) Ju Dong Yang et al. GENES CHROMOSOMES & CANCER
- The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
- (2010) Jin-Ping Lai et al. HEPATOLOGY
- Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
- (2010) Eisuke Yasuda et al. HEPATOLOGY RESEARCH
- Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro
- (2010) Mingqian Feng et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma
- (2010) Kenji Yorita et al. LIVER INTERNATIONAL
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
- (2010) L. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
- (2010) K.-P. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
- (2010) Noriyuki Akutsu WORLD JOURNAL OF GASTROENTEROLOGY
- Optimization of tissue processing for immunohistochemistry for the detection of human glypican-3
- (2009) Hirotake Takai et al. ACTA HISTOCHEMICA
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development
- (2009) Ann Ng et al. DEVELOPMENTAL BIOLOGY
- Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
- (2009) Pisit Tangkijvanich et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma
- (2009) Hirotake Takai et al. LIVER INTERNATIONAL
- Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues
- (2008) Daniel Baumhoer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface
- (2008) Alexandra Traister et al. BIOCHEMICAL JOURNAL
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding
- (2008) Mariana I. Capurro et al. DEVELOPMENTAL CELL
- Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
- (2008) Jin-Ping Lai et al. Future Oncology
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
- (2008) Jin-Ping Lai et al. HEPATOLOGY
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
- (2008) Luca Di Tommaso et al. JOURNAL OF HEPATOLOGY
- Glypicans
- (2008) Jorge Filmus et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now